Our results indicate the existence of a mitochondrial stress environment with a lasting negative impact on residual kidney-function at day 30 likely reflecting a renal-tubular dysfunction in the remaining kidney. Further biochemical analyses are ongoing to confirm the nature of this dysfunction allowing the targeting of timely interventions.
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Results: Out of 81 patients (48.2% Male, 51.8% Female), 34 (42%) underwent surgical repair and 47 (58%) had transcatheter procedures. The median ages were 12.6 years for surgery (range, 0.08e68.2) and 7.8 years (range, 0.01e77.8) in the catheterization group. Mean follow-up times were: 5.3 years (range, 0e13.0) for the surgical group and 4.6 years (range, 0e12.7) for the catheter group. There was no 30-day mortality in the entire cohort. One-year mortality for the surgical group was 7.41 % vs. 2.94 % for the catheter group (p ¼ 0.58). In the catheter group 4 patients (8.51%) required one or more reinterventions, compared to no reinterventions in the surgical cohort (p ¼ 0.13). Conclusions: CCF repair via transcatheter or surgical approach is attainable with no early mortality and good medium-term results. Careful patient selection would have to be partly responsible for these excellent national results Reintervention is overall infrequent and it appears to be higher after transcatheter embolisation. Aim: To investigate the feasibility of elderly patients into living-kidneydonor(LDN) programmes to understand if an upper age limit to doantion should exist. Methods: Details of 10,900 patients undergoing LDN in the UK from 2000e2013 were obtained. Patients were stratified into under 65 and 65+ years populations. Demographics, comorbidity burden, nature/incidence and severity of complications, renal function and proteinuria were analysed using unvariate tests. Results: 586(5.8%) 65+ underwent LDN during 13-year period. Elderly LDN increased from 2.29% to 11.08% during 13-year period(p ¼ 0.000). Older donors were mainly white(96vs86% p ¼ 0.00) with lower deprivation score(mean-IMD:14.9vs21.3 p ¼ 0.001), hypertensive(15.8%vs7.12% p ¼ 0.000), with lower comorbidity burden(ASA2+)(8.19%vs13.32% p ¼ 0.00). BMI, sex and operative factors were similar in groups. The occurrence of minor(Clavien1,2:8.9vs10.1% p¼0.353) and major(Clavien3+:2.39vs1.76% p ¼ 0.263) complications were similar. Mean hospitalstay was equivalent(4.63vs4.42days, p ¼ 0.12). Rises in Syst-BP(3.62vs1.56mmHg p ¼ 0.02) and creatinine(36.7vs30.4 mmol p ¼ 0.000) 1-year postdonation were greater in 65+. New onset proteinuria at 1-year was similar(3.41vs3.51% p ¼ 0.433). Conclusion: Elderly donors comprise an increasing proportion of the donor pool. Perioperative morbidity was similar to younger counterparts. Postoperative measures of cardiovascular risk were within acceptable limits. Continued and increasing use of elderly donors is acceptable, however further data on recipient outcomes assessing the impact on graft function is required. 
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